Timed coadministration of caged-drug payload (albumin-conjugated caged MMAE) and radiopharmaceutical enabled tumor colocalization of the 2 agents, enhanced drug release in tumors, and reduced drug release by 20–3,000 times in off-target tissues. This evidence concerns the gene ALB and neoplasm.